Home › Mylan Pharmaceuticals Inc. › Sodium Chloride Inhalation Solution, USP 0.9% 5mL

Sodium Chloride Inhalation Solution, USP 0.9% 5mL

Mylan Pharmaceuticals Inc. · Model 5mL · UDI-DI 00303786986019

CAF Prescription

510(k) clearances

3,131

Adverse events (43 deaths)

Recalls

190

Facilities

Description

The single-use device is in a color coded unit blow fill sealed container with liquid contents as labeled for inhalation therapy. The device contains no preservative and is sterile and pyrogen free. Primary DI number is for one carton of 100 vials, the lowest saleable unit. Each vial is not sold separately and is not intended to be separated from it's unit of sale.

Recalls

Date	Firm	Reason
2023-08-04	MEDLINE INDUSTRIES, LP - Northfield	Product dispositioned for scrap for sterility failure investigation that was inadvertently shipped to customers.
2021-03-31	Smiths Medical ASD Inc.	The firm became aware via complaints that one lot of ACE MDI Spacers with Small Masks and one lot of Palm Cups (Large) may have incorrect shipping box labels.
2018-08-29	SANRAI INTERNATIONAL LLC	The product was designed for 120V usage and is being used in South Africa with 220V. There is a potential for the device to overheat and the mouthpiece can pop off.
2017-09-05	Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company	Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.
2017-09-05	Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company	Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.
2017-09-05	Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company	Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.
2017-09-05	Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company	Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.
2017-09-05	Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company	Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.
2017-09-05	Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company	Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.
2017-09-05	Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company	Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API key Read the docs

Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.